Theme 1: Opening Ceremony and Keynote Forum |
|
Part 1: Opening Ceremony |
Part 2: Keynote Forum |
Theme 2: Scientific Program |
|
Track 1: Frontiers in Infectious Disease Research |
|
Session 1-1: Genetics and Genomics of Infectious Diseases |
Session 1-2: Infection, Immunity and Inflammation |
Session 1-3: Host-pathogen Interactions |
Session 1-4: Pharmacology of Infectious Diseases |
Session 1-5: Antimicrobial Resistance |
Session 1-6: The Micobiome in Infectious Diseases |
Track 2: Advanced Diagnostics and Treatments for Infectious Diseases |
|
Session 2-1: Artificial Intelligence and Machine Learning for the Diagnosis of Infectious Diseases |
Session 2-2: Point-of-care Infectious Diseases Testing
|
Session 2-3: Next-generation Sequencing for Infectious Diseases Diagnosis |
Session 2-4: Microfluidic Diagnostic Technologies |
Session 2-5: CRISPR-based Diagnostics |
Session 2-6: New Imaging Technologies |
Session 2-7: Biosensors and Nanotechnology |
Session 2-8: Telemedicine and Mobile health (mHealth) |
Session 2-9: Precision Medicine |
Session 2-10: Antimicrobial Immunotherapy |
Session 2-11: Antimicrobial Peptides |
Session 2-12: Traditional Medicines |
Track 3: Viral Infectious Diseases |
|
Session 3-1: COVID-19 |
Session 3-2: Ebola and Zika Viral Infections |
Session 3-3: HIV/AIDS, STDs & STIs |
Session 3-4: Viral Hepatitis |
Session 3-5: Influenza |
Session 3-6: Respiratory Syncytial Virus |
Session 3-7: Nipah Virus |
Session 3-8: Hendra Virus |
Track 4: Bacterial Infectious Diseases |
|
Session 4-1: Tuberculosis |
Session 4-2: Hospital-acquired Infections |
Session 4-3: Emerging Bacterial Pathogens |
Session 4-4: Staphylococcus Aureus (MRSA) |
Session 4-5: Clostridioides difficile (C. Diff) |
Session 4-6: Neisseria Gonorrhoeae (Gonorrhea) |
Track 5: Fungal and Parasitic Infectious Diseases |
|
Session 5-1: Emerging Fungal Infections |
Session 5-2: Invasive Aspergillosis |
Session 5-3: Cryptococcal Meningitis |
Session 5-4: Candida Infections |
Session 5-5: Ringworm |
Session 5-6: Emerging Yeast Infections |
Session 5-7: Malaria |
Session 5-8: Schistosomiasis |
Session 5-9: Leishmaniasis |
Session 5-10: Chagas Disease |
Track 6: Other Infectious Diseases |
|
Session 6-1: Neuro Infectious Diseases |
Session 6-2: Neglected Tropical Diseases |
Session 6-3: Vector-borne Diseases |
Session 6-4: Foodborne Illnesses |
Session 6-5: Blood Infectious Diseases |
Session 6-6: Pediatric Infectious Diseases |
Track 7: New Antimicrobial Drugs R & D |
|
Session 7-1: New Antimicrobial Targets Discovery and Validation |
Session 7-2: Hit Identification and Optimization |
Session 7-3: Pharmacokinetics/Pharmacodynamics Analysis |
Session 7-4: New Antimicrobial Drugs Delivery and Formulation |
Track 8: Global Epidemiology and Public Health |
|
Session 8-1: New Vaccines and Intervention Research |
Session 8-2: Infectious Disease Surveillance and Digital Health Solutions |
Session 8-3: Emerging Infections and Outbreak Response |
8-4: Infectious Diseases Prevention |
Theme 3: Posters & Exhibition |
|
Part 1: Posters |
Part 2: Exhibition |
Theme 4: Social and Cultural Activities |
|
Activity 1: Welcome Banquet and Art Performance |
Activity 2: Lecture Tours to Campus |
Activity 3: Visit to Industrial Park or Companies |
Activity 4: Local Impression Tech-Tour |
● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
● REGISTER NOW to secure your attendance
● Program will be released soon
● Call for co-organizers, supporting organizations
● Call for collaborative partners, media and journal
● Call for exhibitors, and posters
Copyright © 2003-2025 BIT Congress Inc.
Contact us: jodie.jiang@gala-loc.com